Product Code: GVR-2-68038-114-6
Liquid Handling Technology Market Growth & Trends:
The global liquid handling technology market size was estimated at USD 9.63 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 8.76% from 2024 to 2030. The market is experiencing rapid growth, primarily driven by the rise in assays being performed for various research purposes, such as target screening, which has significantly boosted the demand for liquid handling technologies. In recent years, the market has demonstrated substantial expansion potential due to the growth of the pharmaceutical and biotechnology industries, particularly in the R&D sector, and the growth of life science research. Manufacturers have developed workstations utilizing various technologies to dispense droplets from the dispensing tool, overcoming surface adhesion. These technologies encompass ultrasound, piezoelectric, and solenoid mechanisms. For instance, LABCYTE Inc. employs Echo acoustic liquid handling technology in its products, offering non-contact dispensing capabilities.
In addition, effective miniaturization of assay platforms reduces workflow expenses, leading to reduced usage of costly reagents. These miniaturized platforms are designed for highly precise liquid handling in processes, such as plate washing, bulk dispensing, and liquid transfer. The outbreak of COVID-19 resulted in a significant increase in the demand for diagnostic testing, vaccine development, and virus-related research. As a result, the need for liquid handling solutions, such as automated liquid handlers, pipettes, and dispensers,increased. These technologies proved to be essential for efficient and precise sample processing, particularly during the pandemic. The urgent requirement for COVID-19 diagnostics, treatments, and vaccines accelerated research and development efforts. Liquid handling technologies played a crucial role in automating and streamlining laboratory workflows, empowering scientists to efficiently process a large volume of samples and conduct experiments with enhanced efficiency.
Liquid Handling Technology Market Report Highlights:
- The consumables product segment dominated the market in 2022 owing to high usage in laboratories
- The semi-automated liquid handling type segment held the largest share of 41.40% in 2022 due to its higher accuracy and cost-effectiveness compared to fully automated systems
- The drug discovery & ADME-Tox research application segment held the largest share of 37.86% in 2022 playing a crucial role in advancing the development of new drugs
- The academic & research institutes end-use segment accounted for the largest share of 41.49% in 2022 driven by academic and research institutes' involvement in life science experiments, especially those involving gene sequencing and antibody testing
- North America established a strong regional position, capturing a 40% share of the overall revenue in 2022 primarily due to the well-established distribution network of major market players and the rapid adoption of advanced automation solutions
Table of Contents
Chapter 1. Methodology And Scope
- 1.1. Market Segmentation And Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product Segment
- 1.1.1.2. Type Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. End-use segment
- 1.2. Regional Scope
- 1.3. Estimates And Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information Or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List Of Primary Sources
- 1.11. List Of Abbreviations
Chapter 2. Liquid Handling Technology Market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Products And Type Snapshots
- 2.3. Application And End-use Snapshot
- 2.4. Competitive Landscape Snapshot
Chapter 3. Liquid Handling Technology Market Variables, Trends, & Scope
- 3.1. Market Segmentation And Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Drivers Analysis
- 3.4.1. Increase in investment in drug development, clinical trials, and life sciences R&D
- 3.4.2. Rapid adoption of automation
- 3.4.3. Increasing wages of skilled employees in developed countries
- 3.4.4. Demand for effective miniaturization
- 3.5. Market Restraint Analysis
- 3.5.1. High cost of instruments and complex operability of advanced systems
- 3.5.2. Lack of skilled professionals and research support in undeveloped countries
- 3.6. Liquid Handling Technology Market Analysis Tools
- 3.6.1. Industry Analysis - Porter's
- 3.6.1.1. Supplier Power
- 3.6.1.2. Buyer Power
- 3.6.1.3. Substitution Threat
- 3.6.1.4. Threat Of New Entrant
- 3.6.1.5. Competitive Rivalry
- 3.6.2. PESTLE Analysis
- 3.6.2.1. Political Landscape
- 3.6.2.2. Technological Landscape
- 3.6.2.3. Economic Landscape
Chapter 4. Liquid Handling Technology: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Liquid Handling Technology Market By Product Outlook
- 4.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
- 4.4.1. Automated Workstations
- 4.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.1.1.1. Standalone Workstations
- 4.4.1.1.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.1.1.2. Integrated Workstations
- 4.4.1.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2. Small Devices
- 4.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1. Pipettes
- 4.4.2.1.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1.1.1. Electronic Pipettes
- 4.4.2.1.1.1.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1.1.2. Manual Pipettes
- 4.4.2.1.1.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1.1.3. Pipettes Controllers
- 4.4.2.1.1.1.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.2. Burettes
- 4.4.2.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.3. Dispensers
- 4.4.2.1.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.4. Others
- 4.4.2.1.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.3. Consumables
- 4.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.3.1.1. Reagents
- 4.4.3.1.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.3.1.2. Disposable Tips
- 4.4.3.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.3.1.3. Tubes & Plates
- 4.4.3.1.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 4.4.3.1.4. Others
- 4.4.3.1.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 5. Liquid Handling Technology: Type Estimates & Trend Analysis
- 5.1. Type Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Liquid Handling Technology Market By Type Outlook
- 5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
- 5.4.1. Automated Liquid Handling
- 5.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 5.4.2. Manual Liquid Handling
- 5.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 5.4.3. Semi-automated Liquid Handling
- 5.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 6. Liquid Handling Technology: Application Estimates & Trend Analysis
- 6.1. Application Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Liquid Handling Technology Market By Application Outlook
- 6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
- 6.4.1. Drug Discovery & & ADME-Tox Research
- 6.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 6.4.2. Cancer & Genomic Research
- 6.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 6.4.3. Bioprocessing/Biotechnology
- 6.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 6.4.4. Others
- 6.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 7. Liquid Handling Technology: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. Global Liquid Handling Technology Market By End-use Area Outlook
- 7.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
- 7.4.1. Pharmaceutical & & Biotechnology Companies
- 7.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 7.4.2. Contract Research Organization (CRO)
- 7.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 7.4.3. Academic & Research Institutes
- 7.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key Country Dynamics
- 8.5.1.2. Competitive Scenario
- 8.5.1.3. Regulatory Framework
- 8.5.1.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key Country Dynamics
- 8.6.1.2. Competitive Scenario
- 8.6.1.3. Regulatory Framework
- 8.6.1.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.3. Spain
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.4. France
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.5. Italy
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.6. Denmark
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competitive Scenario
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Competitive Scenario
- 8.6.7.3. Regulatory Framework
- 8.6.7.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.6.8. Norway
- 8.6.8.1. Key Country Dynamics
- 8.6.8.2. Competitive Scenario
- 8.6.8.3. Regulatory Framework
- 8.6.8.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key Country Dynamics
- 8.7.1.2. Competitive Scenario
- 8.7.1.3. Regulatory Framework
- 8.7.1.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.7.4. South Korea
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.7.5. Thailand
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.7.6. Australia
- 8.7.6.1. Key Country Dynamics
- 8.7.6.2. Competitive Scenario
- 8.7.6.3. Regulatory Framework
- 8.7.6.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key Country Dynamics
- 8.8.1.2. Competitive Scenario
- 8.8.1.3. Regulatory Framework
- 8.8.1.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.8.2. Mexico
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. Mexico Liquid Handling Technology Market, 2018 - 2030 (USD Million)
- 8.8.3. Argentina
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.9. MEA
- 8.9.1. MEA Liquid Handling Technology Market, 2018 - 2030 (USD Million)
- 8.9.2. South Africa
- 8.9.2.1. Key Country Dynamics
- 8.9.2.2. Competitive Scenario
- 8.9.2.3. Regulatory Framework
- 8.9.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.9.3. Saudi Arabia
- 8.9.3.1. Key Country Dynamics
- 8.9.3.2. Competitive Scenario
- 8.9.3.3. Regulatory Framework
- 8.9.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.9.4. UAE
- 8.9.4.1. Key Country Dynamics
- 8.9.4.2. Competitive Scenario
- 8.9.4.3. Regulatory Framework
- 8.9.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
- 8.9.5. Kuwait
- 8.9.5.1. Key Country Dynamics
- 8.9.5.2. Competitive Scenario
- 8.9.5.3. Regulatory Framework
- 8.9.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company /Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List Of Key Distributors And Channel Partners
- 9.3.2. Key Customers
- 9.3.3. Key Company Market Share Analysis, 2023
- 9.3.4. Thermo Fisher Scientific, Inc
- 9.3.4.1. Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Aglient Technologies, Inc
- 9.3.5.1. Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Aurora Biomed, Inc.
- 9.3.6.1. Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Autogen, Inc
- 9.3.7.1. Overview
- 9.3.7.2. Financial Performance
- 9.3.7.3. Product Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Danaher
- 9.3.8.1. Overview
- 9.3.8.2. Financial Performance
- 9.3.8.3. Product Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. BioTek Instrument, Inc.
- 9.3.9.1. Overview
- 9.3.9.2. Financial Performance
- 9.3.9.3. Product Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. Bio-Rad Laboratories
- 9.3.10.1. Overview
- 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.10.3. Product Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.11. Analytik Jena AG
- 9.3.11.1. Overview
- 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.11.3. Product Benchmarking
- 9.3.11.4. Strategic Initiatives
- 9.3.12. Corning Incorporated
- 9.3.12.1. Overview
- 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.12.3. Product Benchmarking
- 9.3.12.4. Strategic Initiatives
- 9.3.13. Eppendorf SE
- 9.3.13.1. Overview
- 9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.13.3. Product Benchmarking
- 9.3.13.4. Strategic Initiatives
- 9.3.14. Formulatrix, Inc.
- 9.3.14.1. Overview
- 9.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.14.3. Product Benchmarking
- 9.3.14.4. Strategic Initiatives
- 9.3.15. Gilson, Inc.
- 9.3.15.1. Overview
- 9.3.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.15.3. Product Benchmarking
- 9.3.15.4. Strategic Initiatives
- 9.3.16. Hamilton Company
- 9.3.16.1. Overview
- 9.3.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.16.3. Product Benchmarking
- 9.3.16.4. Strategic Initiatives
- 9.3.17. Hudson Robotics
- 9.3.17.1. Overview
- 9.3.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.17.3. Product Benchmarking
- 9.3.17.4. Strategic Initiatives
- 9.3.18. Labcyte, Inc
- 9.3.18.1. Overview
- 9.3.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.18.3. Product Benchmarking
- 9.3.18.4. Strategic Initiatives
- 9.3.19. Lonza
- 9.3.19.1. Overview
- 9.3.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.19.3. Product Benchmarking
- 9.3.19.4. Strategic Initiatives
- 9.3.20. Perkin Elmer, Inc
- 9.3.20.1. Overview
- 9.3.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.20.3. Product Benchmarking
- 9.3.20.4. Strategic Initiatives
- 9.3.21. Qiagen
- 9.3.21.1. Overview
- 9.3.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.21.3. Product Benchmarking
- 9.3.21.4. Strategic Initiatives
- 9.3.22. Tecan Trading AG
- 9.3.22.1. Overview
- 9.3.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.22.3. Product Benchmarking
- 9.3.22.4. Strategic Initiatives
- 9.3.23. Sartorius
- 9.3.23.1. Overview
- 9.3.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.23.3. Product Benchmarking
- 9.3.23.4. Strategic Initiatives
- 9.3.24. Mettler Toledo
- 9.3.24.1. Overview
- 9.3.24.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.24.3. Product Benchmarking
- 9.3.24.4. Strategic Initiatives